01415na  a2200337   4500001001300000005001500013008004100028024002700069035001800096035002700114035002700141100003400168370004800202372004000250372002800290373005200318373003900370373006400409373006100473374004800534375001100582377002200593400002400615400002200639400002300661400002200684400002300706670013600729670015800865670005401023KAC20172136020220901085305170714 b aznnnaabn          fa aaa      7 a00000004609032792isni  a(KRI)10395015  a(KISTI)ADPER0000245440  a(KISTI)ADPER89000002621 a나현오,g羅顯午,d1962-  c한국(국명)[韓國]0KSH20000101452nlsh  a약학[藥學]0KSH19980283072nlsh  a임상약학a약물학  a가톨릭대학교 약학과 (교수)s20040301  a가톨릭대학교 산학협력단  a서울성모병원 약제부 (약제부장)s200903t201508  a대한약물역학위해관리학회 (부회장)s201703  a교수(대학)[敎授]0KSH19980114932nlsh  a여성  l한국어l영어1 aLa, Hyoenoh,d1962-1 aLa, Hyeno,d1962-1 aLa, Hyen-o,d1962-1 a라현오,d1962-1 aNa, Hyenoh,d1962-  a의약품 사용과오 저감화 방안 마련 : 최종보고서, (식품의약품안전처 : 식품의약품안전평가원), 2016  aPractice preferences on dabigatran and rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation, (한국임상약학회), 2016  a한국연구자정보(KRI)uhttps://www.kri.go.kr